This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, N. Articles by Karupiah, G. Search for Related Content PubMed PubMed Citation Articles by Harris, N. Articles by Karupiah, G.

 Previous Article  |  Next Article 

J. Virol., Feb 1995, 910-915, Vol 69, No. 2
Copyright © 1995, American Society for Microbiology

Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication

N Harris, RM Buller and G Karupiah
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.

Gamma interferon (IFN-gamma)-induced nitric oxide synthase (iNOS) and nitric oxide (NO) production in the murine macrophage-like RAW 264.7 cells were previously shown to inhibit the replication of the poxviruses vaccinia virus (VV) and ectromelia virus and herpes simplex virus type 1. In the current study, we performed biochemical analyses to determine the stage in the viral life cycle blocked by IFN-gamma- induced NO. Antibodies specific for temporally expressed viral proteins, a VV-specific DNA probe, and transmission electron microscopy were used to show that the cytokine-induced NO inhibited late protein synthesis, DNA replication, and virus particle formation but not expression of the early proteins analyzed. Essentially similar results were obtained with hydroxyurea and cytosine arabinoside, inhibitors of DNA replication. Enzymatically active iNOS was detected in the lysates of IFN-gamma-treated but not in untreated RAW 264.7 cells. The IFN- gamma-treated RAW 264.7 cells which express iNOS not only were resistant to productive infection but also efficiently blocked the replication of VV in infected bystander cells of epithelial origin. This inhibition was arginine dependent, correlated with nitric production in cultures, and was reversible by the NOS inhibitor N omega- monomethyl-L-arginine.

This article has been cited by other articles:

• Takhampunya, R., Padmanabhan, R., Ubol, S. (2006). Antiviral action of nitric oxide on dengue virus type 2 replication.. J. Gen. Virol. 87: 3003-3011 [Abstract] [Full Text]  
• Mathew, A., Terajima, M., West, K., Green, S., Rothman, A. L., Ennis, F. A., Kennedy, J. S. (2005). Identification of Murine Poxvirus-Specific CD8+ CTL Epitopes with Distinct Functional Profiles. J. Immunol. 174: 2212-2219 [Abstract] [Full Text]  
• Snyder, J. T., Belyakov, I. M., Dzutsev, A., Lemonnier, F., Berzofsky, J. A. (2004). Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8+ T-Cell Peptide Epitope of Vaccinia and Variola Viruses. J. Virol. 78: 7052-7060 [Abstract] [Full Text]  
• Nomura, I., Goleva, E., Howell, M. D., Hamid, Q. A., Ong, P. Y., Hall, C. F., Darst, M. A., Gao, B., Boguniewicz, M., Travers, J. B., Leung, D. Y. M. (2003). Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes. J. Immunol. 171: 3262-3269 [Abstract] [Full Text]  
• Okazaki, T., Pendleton, C. D., Lemonnier, F., Berzofsky, J. A. (2003). Epitope-Enhanced Conserved HIV-1 Peptide Protects HLA-A2-Transgenic Mice Against Virus Expressing HIV-1 Antigen. J. Immunol. 171: 2548-2555 [Abstract] [Full Text]  
• Belyakov, I. M., Earl, P., Dzutsev, A., Kuznetsov, V. A., Lemon, M., Wyatt, L. S., Snyder, J. T., Ahlers, J. D., Franchini, G., Moss, B., Berzofsky, J. A. (2003). Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc. Natl. Acad. Sci. USA 100: 9458-9463 [Abstract] [Full Text]  
• Kosugi, I., Kawasaki, H., Arai, Y., Tsutsui, Y. (2002). Innate Immune Responses to Cytomegalovirus Infection in the Developing Mouse Brain and Their Evasion by Virus-Infected Neurons. Am. J. Pathol. 161: 919-928 [Abstract] [Full Text]  
• Davis, I. C., Zajac, A. J., Nolte, K. B., Botten, J., Hjelle, B., Matalon, S. (2002). Elevated Generation of Reactive Oxygen/Nitrogen Species in Hantavirus Cardiopulmonary Syndrome. J. Virol. 76: 8347-8359 [Abstract] [Full Text]  
• Johnson, T. R., Fischer, J. E., Graham, B. S. (2001). Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J. Gen. Virol. 82: 2107-2116 [Abstract] [Full Text]  
• Ahlers, J. D., Belyakov, I. M., Matsui, S., Berzofsky, J. A. (2001). Mechanisms of cytokine synergy essential for vaccine protection against viral challenge. Int Immunol 13: 897-908 [Abstract] [Full Text]  
• Benencia, F., Courrèges, M. C., Gamba, G., Cavalieri, H., Massouh, E. J. (2001). Effect of Aminoguanidine, a Nitric Oxide Synthase Inhibitor, on Ocular Infection with Herpes Simplex Virus in Balb/c Mice. IOVS 42: 1277-1284 [Abstract] [Full Text]  
• Presti, R. M., Popkin, D. L., Connick, M., Paetzold, S., Virgin, H. W. , IV (2001). Novel Cell Type-specific Antiviral Mechanism of Interferon {{gamma}} Action in Macrophages. J. Exp. Med. 193: 483-496 [Abstract] [Full Text]  
• Stojdl, D. F., Abraham, N., Knowles, S., Marius, R., Brasey, A., Lichty, B. D., Brown, E. G., Sonenberg, N., Bell, J. C. (2000). The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus. J. Virol. 74: 9580-9585 [Abstract] [Full Text]  
• Gherardi, M. M., Ramírez, J. C., Esteban, M. (2000). Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide. J. Virol. 74: 6278-6286 [Abstract] [Full Text]  
• Wieland, S. F., Guidotti, L. G., Chisari, F. V. (2000). Intrahepatic Induction of Alpha/Beta Interferon Eliminates Viral RNA-Containing Capsids in Hepatitis B Virus Transgenic Mice. J. Virol. 74: 4165-4173 [Abstract] [Full Text]  
• Arichi, T., Saito, T., Major, M. E., Belyakov, I. M., Shirai, M., Engelhard, V. H., Feinstone, S. M., Berzofsky, J. A. (2000). Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Proc. Natl. Acad. Sci. USA 97: 297-302 [Abstract] [Full Text]  
• Zaragoza, C., Ocampo, C. J., Saura, M., Bao, C., Leppo, M., Lafond-Walker, A., Thiemann, D. R., Hruban, R., Lowenstein, C. J. (1999). Inducible Nitric Oxide Synthase Protection Against Coxsackievirus Pancreatitis. J. Immunol. 163: 5497-5504 [Abstract] [Full Text]  
• Rimmelzwaan, G. F., Baars, M. M. J. W., de Lijster, P., Fouchier, R. A. M., Osterhaus, A. D. M. E. (1999). Inhibition of Influenza Virus Replication by Nitric Oxide. J. Virol. 73: 8880-8883 [Abstract] [Full Text]  
• Chen, F., Lu, Y., Castranova, V., Rojanasakul, Y., Miyahara, K., Shizuta, Y., Vallyathan, V., Shi, X., Demers, L. M. (1999). Nitric Oxide Inhibits HIV Tat-Induced NF-{kappa}B Activation. Am. J. Pathol. 155: 275-284 [Abstract] [Full Text]  
• Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M., Kurimoto, M. (1999). Interleukin-18 Protects Mice against Acute Herpes Simplex Virus Type 1 Infection. J. Virol. 73: 2401-2409 [Abstract] [Full Text]  
• Lin, Y.-L., Liao, C.-L., Chen, L.-K., Yeh, C.-T., Liu, C.-I, Ma, S.-H., Huang, Y.-Y., Huang, Y.-L., Kao, C.-L., King, C.-C. (1998). Study of Dengue Virus Infection in SCID Mice Engrafted with Human K562 Cells. J. Virol. 72: 9729-9737 [Abstract] [Full Text]  
• Pope, M., Marsden, P. A., Cole, E., Sloan, S., Fung, L. S., Ning, Q., Ding, J. W., Leibowitz, J. L., Phillips, M. J., Levy, G. A. (1998). Resistance to Murine Hepatitis Virus Strain 3 Is Dependent on Production of Nitric Oxide. J. Virol. 72: 7084-7090 [Abstract] [Full Text]  
• Reiss, C. S., Komatsu, T. (1998). Does Nitric Oxide Play a Critical Role in Viral Infections?. J. Virol. 72: 4547-4551 [Full Text]  
• Lopez-Guerrero, J. A., Carrasco, L. (1998). Effect of Nitric Oxide on Poliovirus Infection of Two Human Cell Lines. J. Virol. 72: 2538-2540 [Abstract] [Full Text]  
• Sanders, S. P., Siekierski, E. S., Porter, J. D., Richards, S. M., Proud, D. (1998). Nitric Oxide Inhibits Rhinovirus-Induced Cytokine Production and Viral Replication in a Human Respiratory Epithelial Cell Line. J. Virol. 72: 934-942 [Abstract] [Full Text]  
• Adler, H., Beland, J. L., Del-Pan, N. C., Kobzik, L., Brewer, J. P., Martin, T. R., Rimm, I. J. (1997). Suppression of Herpes Simplex Virus Type 1 (HSV-1)-induced Pneumonia in Mice by Inhibition of Inducible Nitric Oxide Synthase (iNOS, NOS2). J. Exp. Med. 185: 1533-1540 [Abstract] [Full Text]  
• Lopez-Guerrero, J. A., Rayet, B., Tuynder, M., Rommelaere, J., Dinsart, C. (1997). Constitutive Activation of U937 Promonocytic Cell Clones Selected for Their Resistance to Parvovirus H-1 Infection. Blood 89: 1642-1653 [Abstract] [Full Text]